Previous close | 228.45 |
Open | 228.45 |
Bid | 235.65 x N/A |
Ask | 236.00 x N/A |
Day's range | 228.45 - 228.45 |
52-week range | 179.30 - 236.00 |
Volume | |
Avg. volume | 0 |
Market cap | 175.612B |
Beta (5Y monthly) | 0.85 |
PE ratio (TTM) | 45.42 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.00 (0.44%) |
Ex-dividend date | 28 Jun 2024 |
1y target est | N/A |
Remember Abcam? The Cambridge-based biotech was a darling of the Aim market until it decided in late-2022 to abandon London in favour of a listing on the US exchange Nasdaq.
Danaher (DHR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Markel (MKL) first-quarter results reflect improved earned premiums and increased net investment income.